WELS.DE vs. CIB0.DE
WELS.DE (Amundi S&P Global Health Care ESG UCITS ETF EUR Acc) and CIB0.DE (VanEck Bionic Engineering UCITS ETF A) are both Health & Biotech Equities funds - WELS.DE tracks the S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care while CIB0.DE tracks the MVIS Global Bionic Healthcare ESG. Both are passively managed. Over the past 3 years, WELS.DE returned 4.22%/yr vs -7.77%/yr for CIB0.DE. A 0.52 correlation means they provide meaningful diversification when combined. WELS.DE charges 0.18%/yr vs 0.55%/yr for CIB0.DE.
Performance
WELS.DE vs. CIB0.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WELS.DE achieves a -0.19% return, which is significantly higher than CIB0.DE's -11.68% return.
WELS.DE
- 1D
- 0.00%
- 1M
- 4.35%
- YTD
- -0.19%
- 6M
- -0.07%
- 1Y
- 13.16%
- 3Y*
- 4.22%
- 5Y*
- —
- 10Y*
- —
CIB0.DE
- 1D
- 0.00%
- 1M
- 2.50%
- YTD
- -11.68%
- 6M
- -11.71%
- 1Y
- -10.87%
- 3Y*
- -7.77%
- 5Y*
- —
- 10Y*
- —
WELS.DE vs. CIB0.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
WELS.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Acc | -0.19% | 1.05% | 7.20% | 2.33% | -3.91% |
CIB0.DE VanEck Bionic Engineering UCITS ETF A | -11.68% | -10.00% | 5.16% | 2.09% | -8.46% |
Correlation
The correlation between WELS.DE and CIB0.DE is 0.57, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.57 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Dec 2, 2022 | 0.52 |
The correlation between WELS.DE and CIB0.DE has been stable across timeframes, ranging from 0.51 to 0.57 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WELS.DE vs. CIB0.DE — Risk / Return Rank
WELS.DE
CIB0.DE
WELS.DE vs. CIB0.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi S&P Global Health Care ESG UCITS ETF EUR Acc (WELS.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| WELS.DE | CIB0.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.51 | ||
| Sortino ratioReturn per unit of downside risk | +2.22 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 0.91 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 1.06 | -0.47 | +1.53 |
| Martin ratioReturn relative to average drawdown | 2.45 | -1.10 | +3.55 |
Loading charts...
Drawdowns
WELS.DE vs. CIB0.DE - Drawdown Comparison
The maximum WELS.DE drawdown since its inception was -23.13%, smaller than the maximum CIB0.DE drawdown of -32.60%. Use the drawdown chart below to compare losses from any high point for WELS.DE and CIB0.DE.
Loading charts...
Drawdown Indicators
| WELS.DE | CIB0.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -23.13% | -32.60% | +9.47% |
Max Drawdown (1Y)Largest decline over 1 year | -12.35% | -23.47% | +11.12% |
Max Drawdown (3Y)Largest decline over 3 years | -23.13% | -32.60% | +9.47% |
Current DrawdownCurrent decline from peak | -9.21% | -26.17% | +16.96% |
Average DrawdownAverage peak-to-trough decline | -7.26% | -11.12% | +3.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.37% | 9.91% | -4.54% |
Volatility
WELS.DE vs. CIB0.DE - Volatility Comparison
Amundi S&P Global Health Care ESG UCITS ETF EUR Acc (WELS.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE) have volatilities of 5.31% and 5.47%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WELS.DE | CIB0.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.31% | 5.47% | -0.16% |
Volatility (6M)Calculated over the trailing 6-month period | 10.65% | 12.99% | -2.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.90% | 17.33% | -2.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.72% | 18.05% | -4.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13.72% | 18.05% | -4.33% |
WELS.DE vs. CIB0.DE - Expense Ratio Comparison
WELS.DE has a 0.18% expense ratio, which is lower than CIB0.DE's 0.55% expense ratio.
Dividends
WELS.DE vs. CIB0.DE - Dividend Comparison
Neither WELS.DE nor CIB0.DE has paid dividends to shareholders.
Frequently Asked Questions
WELS.DE and CIB0.DE have a correlation of 0.57, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WELS.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WELS.DE is cheaper with a 0.18% expense ratio, compared with 0.55% for CIB0.DE.
WELS.DE tracks S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care, while CIB0.DE tracks MVIS Global Bionic Healthcare ESG. They also come from different issuers: Amundi and VanEck. Their fees differ too: 0.18% for WELS.DE and 0.55% for CIB0.DE.
Find the right allocation for WELS.DE and CIB0.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer